<p>Philip Tsai, Chief Technical Officer of Immunome Inc., reported the acquisition of common shares of Immunome Inc. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunome Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002026600-25-000004), on December 22, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

IMNM

<p>Philip Tsai, CTO of Immunome Inc., has acquired common shares of the company. This information was disclosed via a filing on the EDGAR system by Immunome Inc. on December 22, 2025. The news was generated by Public Technologies using AI and is for informational purposes only.</p>

Immunome CTO Philip Tsai Reports Acquisition of Common Shares